Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/28596
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Dinh, Thien | - |
dc.contributor.author | Panopoulos, Harris | - |
dc.contributor.author | Poniger, Stan | - |
dc.contributor.author | Scott, Andrew M | - |
dc.date | 2021-12-28 | - |
dc.date.accessioned | 2022-01-18T04:46:13Z | - |
dc.date.available | 2022-01-18T04:46:13Z | - |
dc.date.issued | 2022-03 | - |
dc.identifier.citation | Applied Radiation and Isotopes 2022; 181: 110052 | en |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/28596 | - |
dc.description.abstract | 86Y (t1/2 = 14.74 h, 32% β+) has significant potential in theranostic applications as a simultaneous PET imaging partner to 90Y-labelled antibody therapy. However, the complex and costly nature of producing 86Y has led to this radiometal being difficult for hospitals and researchers to obtain. The aim of this work was to develop a simple and cost-efficient method for safely producing 86Y. Our approach was twofold: to develop a method of target preparation that would significantly increase the cost efficiency of producing 86Y, and to design and construct an automated purification system that would eliminate manual radiation handling risks and exposure. Multiple automated productions of high radionuclidic purity (99.45%) 86Y were performed resulting in saturation yields of between 518 MBq/μA and 1332 MBq/μA, dependent on target thickness. | en |
dc.language.iso | eng | - |
dc.subject | Cyclotron | en |
dc.subject | Isotope | en |
dc.subject | Solid target | en |
dc.subject | Yttrium-86 | en |
dc.title | Automated processing of solid target 86Y using enriched SrO powder. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | Applied Radiation and Isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine | en |
dc.identifier.affiliation | Molecular Imaging and Therapy | en |
dc.identifier.affiliation | Olivia Newton-John Cancer Research Institute | en |
dc.identifier.affiliation | Faculty of Medicine, University of Melbourne, Melbourne, Australia | en |
dc.identifier.affiliation | School of Cancer Medicine, La Trobe University, Melbourne, Australia | en |
dc.identifier.pubmeduri | https://pubmed.ncbi.nlm.nih.gov/35032841/ | en |
dc.identifier.doi | 10.1016/j.apradiso.2021.110052 | en |
dc.type.content | Text | en |
dc.identifier.orcid | 0000-0002-6656-295X | en |
dc.identifier.orcid | 0000-0001-5208-8225 | en |
dc.identifier.pubmedid | 35032841 | - |
local.name.researcher | Poniger, Stan | |
item.languageiso639-1 | en | - |
item.fulltext | No Fulltext | - |
item.grantfulltext | none | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
item.openairetype | Journal Article | - |
crisitem.author.dept | Molecular Imaging and Therapy | - |
crisitem.author.dept | Molecular Imaging and Therapy | - |
crisitem.author.dept | Olivia Newton-John Cancer Research Institute | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.